Healthcare & Life Sciences Private Equity Deal Tracker: DWHP Invests in LKC Technologies

Amber McGraw Walsh
McGuireWoods LLP
Contact
LinkedIn
Facebook
X
Send
Embed

DW Healthcare Partners (DWHP) has announced it has completed an investment in LKC Technologies.

LKC, based in Gaithersburg, Md., is a manufacturer of electrophysiology testing devices. Founded in 1975, the company’s flagship product is RETeval, a handheld electroretinography and visual evoked potential device used to aid in the diagnosis and management of retina and optic nerve diseases.

DWHP, with its U.S. office in Park City, Utah, is a healthcare-focused private equity firm. Founded in 2002, the firm prefers to make shareholder liquidity, management buyout and growth capital investments in mid-to-late-stage companies.

Terms of the investment were not disclosed.

Send Print Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McGuireWoods LLP | Attorney Advertising

Written by:

McGuireWoods LLP
McGuireWoods LLP
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

McGuireWoods LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign Up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide